KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Castle Biosciences (CSTL) Times Interest Earned (2018 - 2025)

Castle Biosciences (CSTL) has disclosed Times Interest Earned for 8 consecutive years, with -$159.46 as the latest value for Q4 2025.

  • Quarterly Times Interest Earned fell 462.23% to -$159.46 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$497.79 through Dec 2025, down 3091.34% year-over-year, with the annual reading at -$497.79 for FY2025, 3412.86% down from the prior year.
  • Times Interest Earned hit -$159.46 in Q4 2025 for Castle Biosciences, up from -$283.5 in the prior quarter.
  • In the past five years, Times Interest Earned ranged from a high of $44.02 in Q4 2024 to a low of -$15171.0 in Q4 2021.
  • Historically, Times Interest Earned has averaged -$3462.7 across 5 years, with a median of -$1642.8 in 2025.
  • Biggest five-year swings in Times Interest Earned: crashed 197543.3% in 2021 and later surged 101.56% in 2024.
  • Year by year, Times Interest Earned stood at -$15171.0 in 2021, then surged by 62.38% to -$5708.0 in 2022, then soared by 50.44% to -$2829.0 in 2023, then soared by 101.56% to $44.02 in 2024, then plummeted by 462.23% to -$159.46 in 2025.
  • Business Quant data shows Times Interest Earned for CSTL at -$159.46 in Q4 2025, -$283.5 in Q3 2025, and -$202.43 in Q2 2025.